Showing results (541-550 of 782) with videos related to
Sort By:
Pageof 79
Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.Blood Advances|July 26, 2022
Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15Rafael Alonso Fernandez, Jessica Encinas Mayoral, Laetitia Pierre-Louis, et al.British Journal of Haematology|September 16, 2009
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M Negri, Douglas W McMillin, Jake Delmore, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applicationsSteven P Treon, Linda M Pilarski, Andrew R Belch, et al.Blood Advances|December 7, 2020
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myelomaNikhil C Munshi, Herve Avet-Loiseau, Kenneth C Anderson, et al.Blood Cancer Journal|July 15, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myelomaXueping Wan, Ting Du, Teng Fang, et al.British Journal of Haematology|May 8, 2013
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activityMoshe E Gatt, Kohichi Takada, Mala Mani, et al.Blood|November 18, 2021
IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WMAbdul Hamid Bazarbachi, Hervé Avet-Loiseau, Raphael Szalat, et al.Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.British Journal of Haematology|November 7, 2008
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitorPaola Neri, Pierosandro Tagliaferri, Maria Teresa Di Martino, et al.Pageof 79